# A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia

> **NCT00222794** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 66 (—)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Atomoxetine (Strattera)

## Key facts

- **NCT ID:** NCT00222794
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 66 (—)
- **Last updated:** 2010-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222794, "A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00222794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*